These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 16875614

  • 21. [Comparison of treatment efficacy of the second and the third generations of chemoradiotherapy regimens containing platinum on advanced non-small cell lung cancer].
    Wang YM, Guo LJ, Li LS, Li P, Zheng J, Li L.
    Ai Zheng; 2005 Dec; 24(12):1514-7. PubMed ID: 16351804
    [Abstract] [Full Text] [Related]

  • 22. A phase II study of docetaxel plus nedaplatin in patients with metastatic non-small-cell lung cancer.
    Teramoto K, Asada Y, Ozaki Y, Suzumura Y, Nakano Y, Sawai S, Tezuka N, Inoue S, Fujino S.
    Cancer Chemother Pharmacol; 2012 Oct; 70(4):531-7. PubMed ID: 22864949
    [Abstract] [Full Text] [Related]

  • 23. Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancer.
    Murakami S, Saito H, Kondo T, Ito H, Oshita F, Yamada K.
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):81-87. PubMed ID: 29116379
    [Abstract] [Full Text] [Related]

  • 24. [Comparison of the efficacy of nedaplatin combined with docetaxel and docetaxel alone as a second line treatment for advanced non-small cell lung cancer].
    Gu LP, Shen SP, Chen ZW.
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):939-42. PubMed ID: 21223805
    [Abstract] [Full Text] [Related]

  • 25. Single-institute phase I/II trial of alternating chemoradiotherapy with 5-FU and nedaplatin for esophageal carcinoma.
    Kodaira T, Fuwa N, Kamata M, Furutani K, Tachibana H, Yamazaki T.
    Anticancer Res; 2006 Dec; 26(1B):471-8. PubMed ID: 16739307
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Evaluation of combined chemotherapy including high-dose cisplatin in the treatment of malignant tumors].
    Zhou JC, Feng FY, Sun Y, Wang QL, Zeng WY, Liu YY.
    Zhonghua Zhong Liu Za Zhi; 1987 Mar; 9(2):136-9. PubMed ID: 2820683
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer.
    Yamashita H, Haga A, Takenaka R, Kiritoshi T, Okuma K, Ohtomo K, Nakagawa K.
    Radiat Oncol; 2016 Jan 19; 11():4. PubMed ID: 26781439
    [Abstract] [Full Text] [Related]

  • 31. Nedaplatin- versus cisplatin-based chemotherapy in the survival time of patients with non-small cell lung cancer.
    Shan J, Xiong Y, Wang D, Xu M, Yang YI, Gong K, Yang Z, Wang GE, Yang X.
    Mol Clin Oncol; 2015 May 19; 3(3):543-549. PubMed ID: 26137264
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Combination chemotherapy with Taxol and cisplatin for 57 patients with non-small cell lung cancer by intraartery and intravenous infusion].
    Zhao Y, Wang SM, Zhang J.
    Ai Zheng; 2002 Dec 19; 21(12):1365-7. PubMed ID: 12520750
    [Abstract] [Full Text] [Related]

  • 34. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Dec 19; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 35. Phase I trial of nedaplatin chemotherapy concurrent with radiotherapy for untreated locoregionally advanced nasopharyngeal carcinoma.
    Liang Z, Wang S, Lin Z, Feng S, Cheng Z, Yang Y, Kuang Y, Fidelis C, Ullah S, Li F.
    Cancer Chemother Pharmacol; 2016 Mar 19; 77(3):643-51. PubMed ID: 26831498
    [Abstract] [Full Text] [Related]

  • 36. A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with esophageal cancer.
    Sato Y, Takayama T, Sagawa T, Okamoto T, Miyanishi K, Sato T, Araki H, Iyama S, Abe S, Murase K, Takimoto R, Nagakura H, Hareyama M, Kato J, Niitsu Y.
    Cancer Chemother Pharmacol; 2006 Nov 19; 58(5):570-6. PubMed ID: 16463059
    [Abstract] [Full Text] [Related]

  • 37. [Augmented antitumor efficacy of combination chemotherapy of nedaplatin with 5-fluorouracil in in vivo murine and human tumor model].
    Uchida N, Takeda Y, Kasai H, Hojo K, Wada T, Nishida K, Maekawa R, Sugita K, Yoshioka T.
    Gan To Kagaku Ryoho; 1998 Dec 19; 25(14):2267-74. PubMed ID: 9881084
    [Abstract] [Full Text] [Related]

  • 38. [A case of esophageal carcinoma with multiple liver metastases successfully treated with nedaplatin (NDP) and 5-fluorouracil (5-FU) combined with radiotherapy].
    Kaneko K, Ito H, Ito T, Konishi K, Kurahashi T, Yamamoto T, Eguchi J, Kitahara T, Mitamura K.
    Gan To Kagaku Ryoho; 2001 Jun 19; 28(6):831-4. PubMed ID: 11432353
    [Abstract] [Full Text] [Related]

  • 39. Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.
    Kuwahara A, Yamamori M, Nishiguchi K, Okuno T, Chayahara N, Miki I, Tamura T, Inokuma T, Takemoto Y, Nakamura T, Kataoka K, Sakaeda T.
    Int J Med Sci; 2009 Sep 28; 6(6):305-11. PubMed ID: 19834547
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.